Examples of using Caspofungin in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Distribution plays the prominent role in caspofungin plasma pharmacokinetics and is the rate-controlling step in both the alpha- and beta-disposition phases.
Caspofungin, which is active against the fungal cell wall in Candida
Caspofungin has also been evaluated at 150 mg daily(for up to 51 days) in 100 adult patients see section 5.1.
The European Commission granted a marketing authorisation valid throughout the European Union for Caspofungin MSD to Merck Sharpe and Dohme Limited on 24 October 2001.
Caspofungin is not a substrate for P-glycoprotein
In this group of patients, the safety of caspofungin at this higher dose appeared generally similar to patients receiving the 50-mg daily dose of caspofungin.
In vitro studies show that caspofungin is not an inhibitor of cytochrome P450 enzymes 1A2,
Caspofungin should be initiated by a physician experienced in the management of invasive fungal infections.
In this study, the caspofungin dose was administered over 2 hours instead of the routine 1-hour administration.
In clinical studies, caspofungin did not induce or inhibit the CYP3A4 metabolism of other medicinal products.
For the treatment of oesophageal candidiasis, Mycamine was compared with fluconazole in a study involving 518 adults, and with caspofungin in another study involving 452 adults.
The safety and efficacy of caspofungin was evaluated in paediatric patients 3 months to 17 years of age in two prospective, multicentre clinical trials.
Caspofungin was negative in in vitro assays for potential genotoxicity as well as in the in vivo mouse bone marrow chromosomal test.
successfully treated with Mycamine, fluconazole or caspofungin.
The study compared caspofungin at 50 mg daily(following a 70-mg loading dose on Day 1)
The active substance in Cancidas, caspofungin, belongs to a group of antifungal medicines known as‘echinocandins.
CANCIDAS 50 mg powder for concentrate for solution for infusion Each vial contains 50 mg caspofungin as acetate.
These data suggest that caspofungin can be used in patients receiving cyclosporin when the potential benefit outweighs the potential risk.
EUCAST breakpoints have not yet been established for caspofungin, due to significant inter-laboratory variation in MIC ranges for caspofungin.
CANCIDAS 50 mg powder for concentrate for solution for infusion Caspofungin as acetate.